The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 61 | — | 20.1x | Near average | |
Growth | 19 | 0.4% | 5.6% | Below average | |
Quality | 18 | -0.7% | 7.6% | Below average | |
Safety | 29 | 10.5x | 0.4x | Below average | |
Capital Return | 35 | 1.55% | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
The Chemours Company is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy The Chemours Company shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Chemours stock has experienced a significant decrease in the number of following analysts from 7 to only 3, reflecting a decline in research coverage and an increase in uncertainty surrounding the stock. Although the average price target has stabilized at 25.75 dollars, the large gap between the low (17 dollars) and the high (30 dollars) indicates high Analyst Dispersion, which weakens confidence in the current consensus.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.